Technological advances in diagnosing and treating ocular disease continue to develop at a rapid pace. New diagnostic testing equipment, surgical procedures, and drugs emerge as hot topics during every ophthalmic educational meeting and in various ophthalmic publications. It is both exciting and rewarding to offer these services to patients, yet numerous reimbursement challenges exist with new technology. Science and technology move much faster than coverage and payment policies.
From that perspective, this course examines various considerations that require attention as practices balance the promise of new advances in medicine against the uncertainty or delays in reimbursement.